Secura Bioincis A Pharmaceutical Company Based In Hendersonnevadadedicated To Developing And Commercializing Innovative Therapies For Serious Illnessesthe Company Focuses On Patient Centric Approachesaiming To Provide Life Changing Treatments For Underserved Medical Needsparticularly In Oncology Secura Bio Specializes In Experimental Cancer Drugsincluding Histone Deacetylase Inhibitors And Alkylating Antineoplastic Agentsit Manufactures And Markets Multiple Drugs In The U S With A Notable Emphasis On Therapies For Chronic Lymphocytic Leukemiacll The Company Actively Engages In Clinical Trials And Regulatory Strategiesparticularly In Orphan Drug Designations And Niche Oncology Areasto Advance Its Therapeutic Offerings With A Total Funding Of $105 Millionincluding Significant Investment From Athyrium Capital Managementsecura Bio Holds Five Patents Related To Cancer Treatment Methodologies And Drug Formulationsthe Company Serves Healthcare Providers And Patients In The U S Focusing On Those With Rare Or Complex Cancers
